Treatment of meningococcal infection

Archives of Disease in Childhood

Volumn 88, Issue 7, 2003, Pages 608-614

  Welch, S B ^a   Nadel, S ^b  

^a Paediatric Infectious Diseases   (United States)

^b ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ATROPINE; BICARBONATE; CALCIUM CHLORIDE; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; DEXAMETHASONE; DOBUTAMINE; DOPAMINE; FRESH FROZEN PLASMA; FUROSEMIDE; GELATIN SUCCINATE; GLUCONATE CALCIUM; HUMAN ALBUMIN; LORAZEPAM; MAGNESIUM SULFATE; MANNITOL; MIDAZOLAM; MORPHINE; NORADRENALIN; PARALDEHYDE; PENICILLIN G; PHENYTOIN; POLYGELINE; POTASSIUM; RIFAMPICIN; SUXAMETHONIUM; THIOPENTAL; UNINDEXED DRUG;

ADOLESCENT; ANEMIA; ANESTHESIA; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; ARTIFICIAL VENTILATION; BLOOD CLOTTING DISORDER; BLOOD CULTURE; CHILD; COMPARTMENT SYNDROME; DRUG MEGADOSE; EARLY DIAGNOSIS; ENDOTRACHEAL INTUBATION; ENTERIC FEEDING; FEVER; FLUID THERAPY; HOSPITAL INFECTION; HUMAN; HYPOCALCEMIA; HYPOKALEMIA; HYPOMAGNESEMIA; IATROGENIC DISEASE; INFANT; INTENSIVE CARE; INTRACRANIAL HYPERTENSION; KIDNEY FAILURE; LIMB ISCHEMIA; LIMB SALVAGE; LUMBAR PUNCTURE; LUNG EDEMA; MENINGITIS; MENINGOCOCCOSIS; METABOLIC ACIDOSIS; METABOLIC DISORDER; NEUROLOGICAL COMPLICATION; NEWBORN; NOSE FEEDING; PARENTERAL NUTRITION; PERCEPTION DEAFNESS; PETECHIA; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; REVIEW; SEIZURE; SEPTIC SHOCK; SINGLE DRUG DOSE; SKIN NECROSIS; VACCINATION; CLINICAL PROTOCOL; METHODOLOGY; MICROBIOLOGY;

CHILD; CLINICAL PROTOCOLS; HUMANS; INTENSIVE CARE; INTRACRANIAL HYPERTENSION; MENINGOCOCCAL INFECTIONS; SHOCK, SEPTIC;

EID: 0037590638     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.88.7.608     Document Type: Review

References (47)

1. Public Health Laboratory Service. Statutory notifications of infectious diseases in England & Wales. NOIDS Report: 2001. London: Public Health Laboratory Service, 2002.
2. Pollard AJ, Moxon ER. The meningococcus tamed? Arch Dis Child 2002;87:13-17.
3. Nadel S, Levin M, Habibi P. Treatment of meningococcal disease in childhood. In: Cartwright K, ed. Meningococcal disease. Chichester: Wiley, 1995:207-43.
4. Pollard AJ, Britto J, Nadel S, et al. Emergency management of meningococcal disease. Arch Dis Child 1999;80:290-6.
5. Booy R, Habibi P, Nadel S, et al. Reduction in the case fatality rate from meningococcal disease associated with improved healthcare delivery. Arch Dis Child 2001;85:386-90.
6. Thorburn K, Baines P, Thomson A, et al. Mortality in severe meningococcal disease. Arch Dis Child 2001;85:382-5.
7. Steven N, Wood M. The clinical spectrum of meningococcal disease. In: Cartwright K, ed. Meningococcal disease. Chichester: Wiley, 1995:177-205.
8. Marzouk O, Thomson AP, Sills JA, et al. Features and outcome in meningococcal disease presenting with maculopapular rash. Arch Dis Child 1991;66:485-7.
9. Kirsch EA, Barton RP, Kitchen L, et al. Pathophysiology, treatment and outcome of meningococcemia: a review and recent experience. Pediatr Infect Dis J 1996;15:967-78.
10. Brogan PA, Raffles A. The management of fever and petechiae: making sense of rash decisions. Arch Dis Child 2000;83:506-7.
11. Steihm ER, Damrosch DS. Factors in the prognosis of meningococcal infection. Review of 63 cases with emphasis on recognition and management of the severely ill patient. J Pediatr 1966;68:457-67.
12. Strang JR, Pugh EJ. Meningococcal infections: reducing the case fatality rate by giving penicillin before admission to hospital. BMJ 1992;305:141-3.
13. Carrol ED, Thomson APJ, Shears P, et al. Performance characteristics of the polymerase chain reaction assay to confirm clinical meningococcal disease. Arch Dis Child 2000;83:271-3.
14. Van Deuren M, van Dijke B, Koopman R, et al. Rapid diagnosis of acute meningococcal infections by needle aspiration or biopsy of skin lesions. BMJ 1993;306:1229-32.
15. Poss WB, Brockmeyer DL, Clay B, et al. Pathophysiology and management of the intracran a vault. In: Rogers MC, ed. Textbook of pediatric intensive care. Baltimore: Williams and Wilkins. 1996:645-65.
16. Kneen R, Solomon T, Appleton R. The role of lumbar puncture in suspected CNS infection - a disappearing skill? Arch Dis Child 2002;87:181-3.
17. Riordan FAI, Cant AJ. When to do a lumbar puncture. Arch Dis Child 2002;87:235-7.
18. Nadel S. Lumbar puncture should not be performed in meningococcal disease. Arch Dis Child 2001;84:373.
19. Tobin JR, Wetzel RC. Shock and multiorgan failure. In: Rogers MC, ed. Textbook of pediatric intensive care. Baltimore: Williams and Wilkins, 1996:555-605.
20. Advanced Life Support Group. Advanced paediatric life support, 3rd edn. Manchester: ALSG, 2000.
21. Anon. Proceedings of the Pediatric Septic Shock Consensus Conference, San Antonio, TX, USA, February 2002.
22. Kirkham FJ. Non-traumatic coma in children. Arch Dis Child 2001;85:303-12.
23. Pathan N, Faust S, Levin M. Pathophysiology of meningococcal meningitis and septicaemia. Arch Dis Child 2003;88:601-7.
24. Carcillo JA, Davis AL, Zaritsky A. Role of early fluid resuscitation in pediatric septic shock. JAMA 1991;266:1242-5.
25. Carcillo JA, Fields AI, Task Force Committee Members. Clinical practice parameters for hemodynamic support of pediatric and neonatal patients in septic shock. Crit Care Med 2002;30:1365-78.
26. Cochrane Injuries Group Albumin Reviewers. Human albumin administration in critically ill patients; systematic review of randomised controlled trials. BMJ 1998;317:235-40.
27. Choi PT-L, Yip G, Quinonez LG, et al. Crystalloids vs. colloids in fluid resuscitation: a systematic review. Crit Care Med 1999;27:200-10.
28. Ernest D, Belzberg AS, Dodek PM. Distribution of normal saline and 5% albumin infusions in septic patients. Crit Care Med 1999;27:46-50.
29. Ledingham IM, McArdle CS. Prospective study of the treatment of septic shock. Lancet 1978;i:1194-7.
30. Khilnani P. Electrolyte abnormalities in critically ill children. Crit Care Med 1992;20:241-50.
31. Sarnaik AP, Lieh-Lai MW. Transporting the neurologically compromised child. Pediatr Clin North Am 1993;40:337-54.
32. Britto JF, De-Munter C, Habibi P. Specialised pediatric inter-hospital transfer. In: Intensive care in childhood. Berlin: Springer-Verlag, 1996:146-58.
33. Hatherill M, Tibby SM, Hilliard T, et al. Adrenal insufficiency in septic shock. Arch Dis Child 1999;80:51-5.
34. van Woensel JB, Biezeveld MH, Alders AM, et al. Adrenocorticotropic hormone and cortisol levels in relation to inflammatory response and disease severity in children with meningococcal disease. J Infect Dis 2001;184:1532-7.
35. Lefering R, Neugebauer EA. Steroid controversy in sepsis and septic shock: a meta-analysis. Crit Care Med 1995;23:1294-303.
36. Nadel S, Macintosh I, Levin M. Evaluation of new treatments for meningococcal disease. In: Pollard A, Maiden M, eds. Meningocccal disease, methods and protocols. New Jersey: Humana Press, 2001:549-86.
37. McIntyre PB, Berkey CS, King SM, et al. Dexamethasone as adjunctive therapy in baterial meningitis. A meta-analysis of randomized clinical trials since 1988. JAMA 1997;278:925-31.
38. Odio CM, Faingezicht I, Paris M, et al. The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis. N Engl J Med 1991;324:1525-31.
39. Faust SN, Levin M, Harrison OB, et al. Dysfunction of endothelial protein C activation in severe meningococcal sepsis. N Engl J Med 2001;345:408-16.
40. Davies MS, Nadel S, Habibi P, et al. The orthapaedic management of peripheral ischaemia in meningococcal septicaemia in children. J Bone Joint Surg 2000;82:383-6.
41. Meyer R, Elwig K, Lang A. More is not necessarily better: an overview on calorie requirements in critically ill children. Care of the Critically III 2002;18:93-6.
42. Judge D, Nadel S, Vergnaud S, et al. Psychiatric adjustment following meningococcal disease treated on a PICU. Intensive Care Med 2002;28:648-50.
43. Levin M, Quint PA, Goldstein B, et al. Recombinant bactericidal/permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial. rBPI21 Meningococcal Sepsis Study Group. Lancet 2000;356:961-7.
44. Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001;344:699-709.
45. Siegel JP. Assessing the use of activated protein C in the treatment of severe sepsis. N Engl J Med 2002;374:1030-4.
46. Fellick JM, Sills JA, Marzouk O, et al. Neurodevelopmental outcome in meningococcal disease: a case-control study. Arch Dis Child 2001;85:6-11.
47. Hoare S, El-Shazali O, Clark JE, et al. Investigation for complement deficiency following meningococcal disease. Arch Dis Child 2002;86:215-17.